Middle East and North Africa Conference (MENA)

返回 Agenda

Session 4: Egypt Townhall

Session Chair(s)

Dalia Abou Hussein

Quality Assurance (QA) General Director, Egyptian Drug Authority (EDA), Egypt

In this session hosted by the Egyptian Drug Authority (EDA), Egyptian authorities will present the vision for 2030, opportunities and latest developments in the country.

Speaker(s)

EDA’s Establishment and Efforts towards Alignment with International Standards

Aiman S. El-Khatib

Vice President, Egyptian Drug Authority (EDA), Egypt

EDA Efforts on Investment and Localization within the regulatory framework

Yasin Ragaey

Chairman Assistant for Media affairs & Investment Support in the Pharma Sector, Egyptian Drug Authority (EDA), Egypt

EDA’s path towards International Standards

Asmaa Fouad

Head Central Adm. of Biological, Innov. Products & Clinical Trials, Egyptian Drug Authority, Egypt

Medhat Al-Ghobashy

Former EDA Advisor for Regulatory & Reference Labs, Egyptian Drug Authority (EDA), Egypt

EDA’s collaborative initiatives

Riad Armanious

Vice chairman, Chamber of Pharmaceutical Industry & CEO,, EVA Pharma, Egypt